全文获取类型
收费全文 | 2281817篇 |
免费 | 357462篇 |
国内免费 | 40444篇 |
专业分类
耳鼻咽喉 | 30905篇 |
儿科学 | 75081篇 |
妇产科学 | 59893篇 |
基础医学 | 357742篇 |
口腔科学 | 58973篇 |
临床医学 | 231374篇 |
内科学 | 472293篇 |
皮肤病学 | 49677篇 |
神经病学 | 180921篇 |
特种医学 | 89362篇 |
外国民族医学 | 941篇 |
外科学 | 347397篇 |
综合类 | 94513篇 |
现状与发展 | 1篇 |
一般理论 | 739篇 |
预防医学 | 192513篇 |
眼科学 | 63177篇 |
药学 | 201711篇 |
8篇 | |
中国医学 | 50682篇 |
肿瘤学 | 121820篇 |
出版年
2019年 | 28140篇 |
2018年 | 35107篇 |
2017年 | 30777篇 |
2016年 | 31273篇 |
2015年 | 33513篇 |
2014年 | 41238篇 |
2013年 | 56401篇 |
2012年 | 71296篇 |
2011年 | 76513篇 |
2010年 | 53428篇 |
2009年 | 57521篇 |
2008年 | 71068篇 |
2007年 | 71862篇 |
2006年 | 71805篇 |
2005年 | 69597篇 |
2004年 | 70133篇 |
2003年 | 67198篇 |
2002年 | 65735篇 |
2001年 | 107827篇 |
2000年 | 107376篇 |
1999年 | 95737篇 |
1998年 | 34302篇 |
1997年 | 31015篇 |
1996年 | 31405篇 |
1995年 | 30620篇 |
1994年 | 29154篇 |
1993年 | 26941篇 |
1992年 | 76799篇 |
1991年 | 75175篇 |
1990年 | 72636篇 |
1989年 | 69999篇 |
1988年 | 64508篇 |
1987年 | 63602篇 |
1986年 | 59587篇 |
1985年 | 56907篇 |
1984年 | 42844篇 |
1983年 | 36912篇 |
1982年 | 24275篇 |
1981年 | 22073篇 |
1980年 | 20399篇 |
1979年 | 39452篇 |
1978年 | 28796篇 |
1977年 | 25170篇 |
1976年 | 23529篇 |
1975年 | 24740篇 |
1974年 | 28736篇 |
1973年 | 27598篇 |
1972年 | 25677篇 |
1971年 | 23454篇 |
1970年 | 22009篇 |
排序方式: 共有10000条查询结果,搜索用时 797 毫秒
31.
目的 基于临床信息系统分析总结真实世界的数据,采用数据挖掘的方法探讨中医药治疗糖尿病肾病的用药规律。方法 收集2018年1月-2020年12月上海中医药大学附属曙光医院宝山分院健康信息系统确诊的糖尿病肾病的门诊或住院患者的诊疗信息,建立Excel数据库,采用Excel 2010软件统计高频药物的四气、五味、归经及功效;使用SPSS Modeler 18.0软件中的Apriori算法分析关联规则,采用web节点建构药对关联网状图;运用SPSS 25统计软件进行因子分析。结果 本研究最终纳入477例接受中药饮片治疗的DKD患者,在1203条方剂信息中,涉及中药462种;使用频数排名前5位的中药分别是黄芪、黄精、石斛、山茱萸、麦冬;使用频数前5类的中药类别分别是补气药、补阴药、清热燥湿药、活血调经药、息风止痉药;在30味高频药物中,苦、甘、辛药味最为常见;药性寒、温数量接近;归脾经、肝经、肺经、肾经居多;关联规则提示,药物组合中置信度最高的组合为地龙-当归-僵蚕,因子分析共得到5个有效因子,累积贡献率为47.33%。结论 中医药治疗DKD在补益气血阴阳的同时,兼顾对瘀血、湿邪和痰饮的治疗,结合证型,可考虑使用黄芪、黄精、石斛、山茱萸、麦冬、金蝉花等药物的使用,清热燥湿药物如黄连、黄芩、黄柏可适当加入,为使邪有去处,大黄、车前子或可增添疗效。 相似文献
32.
Marike Gabrielson Mattias Hammarström Magnus Bäcklund Jenny Bergqvist Kristina Lång Ann H Rosendahl Signe Borgquist Roxanna Hellgren Kamila Czene Per Hall 《International journal of cancer. Journal international du cancer》2023,152(11):2362-2372
Tamoxifen prevents recurrence of breast cancer and is suggested for preventive risk-reducing therapy. Tamoxifen reduces mammographic density, a proxy for therapy response, but little is known about its effects in remodelling normal breast tissue. Our study, a substudy within the double-blinded dose-determination trial KARISMA, investigated tamoxifen-specific changes in breast tissue composition and histological markers in healthy women. We included 83 healthy women randomised to 6 months daily intake of 20, 10, 5, 2.5, 1 mg of tamoxifen or placebo. The groups were combined to “no dose” (0-1 mg), “low-dose” (2.5-5 mg) or “high-dose” (10-20 mg) of tamoxifen. Ultrasound-guided biopsies were collected before and after tamoxifen exposure. In each biopsy, epithelial, stromal and adipose tissues was quantified, and expression of epithelial and stromal Ki67, oestrogen receptor (ER) and progesterone receptor (PR) analysed. Mammographic density using STRATUS was measured at baseline and end-of-tamoxifen-exposure. We found that different doses of tamoxifen reduced mammographic density and glandular-epithelial area in premenopausal women and associated with reduced epithelium and increased adipose tissue. High-dose tamoxifen also decreased epithelial ER and PR expressions in premenopausal women. Premenopausal women with the greatest reduction in proliferation also had the greatest epithelial reduction. In postmenopausal women, high-dose tamoxifen decreased the epithelial area with no measurable density decrease. Tamoxifen at both low and high doses influences breast tissue composition and expression of histological markers in the normal breast. Our findings connect epithelial proliferation with tissue remodelling in premenopausal women and provide novel insights to understanding biological mechanisms of primary prevention with tamoxifen. 相似文献
33.
目的 通过分析特发性肺纤维化急性加重期(AE-IPF)患者证候与血清生物标志物的关系,为中医辨证治疗提供参考。方法 采用观察性研究设计,收集2019年3月至2019年11月三个中心的AE-IPF患者76例,其中痰热壅肺证26例、痰浊阻肺证50例,并纳入健康志愿者10例作为对照。采用ELISA测定患者血清CCL18、HMGB1、KL-6、MMP-7、SP-A和SP-D水平,分析与中医证候的相关性。结果 AE-IPF患者血清CCL18、HMGB1、KL-6、MMP-7、SP-A和SP-D水平均显著高于健康对照组。血清CCL18、HMGB1、KL-6、MMP-7和SP-D水平在痰热壅肺证和痰浊阻肺证患者间无显著性差异(P>0.05),而血清SP-A水平存在显著性差异(P<0.05)。结论 血清SP-A与AE-IPF证候存在一定的相关性,血清SP-A的浓度升高,与痰热壅肺证关系越密切,反之,血清SP-A浓度降低,则与痰浊阻肺证关系越密切。AE-IPF痰热壅肺证患者的预后可能较痰浊阻肺证患者更差。 相似文献
34.
目的:建立黑参中人参皂苷Rg_3的含量测定方法。方法:利用高效液相色谱法,采用Thermo色谱柱(250 mm×4.6 mm,5μm),以乙腈-水为流动相梯度洗脱,测定黑参中人参皂苷Rg_3含量。结果:研究表明,不同批次黑参中人参皂苷Rg_3的含量差别明显,平均含量为1.236 5 mg·g~(-1),最低含量为0.368 7 mg·g~(-1),最高含量为2.500 7 mg·g~(-1),相差6.8倍。结论:建立了黑参中人参皂苷Rg_3含量的测定方法,对不同批次样品进行测定后发现,人参皂苷Rg_3含量差别明显,为黑参的质量控制和开发利用提供参考。 相似文献
35.
Xiumei Jiang Xiaowei Zhang Patrick Gray Jiwen Zheng Timothy R. Croley Peter P. Fu 《journal of environmental science and health part c-environmental carcinogenesis & ecotoxicology reviews》2019,37(2):116-131
Gold nanoparticles (Au NPs) hold great promise in food, industrial and biomedical applications due to their unique physicochemical properties. However, influences of the gastrointestinal tract (GIT), a likely route for Au NPs administration, on the physicochemical properties of Au NPs has been rarely evaluated. Here, we investigated the influence of GIT fluids on the physicochemical properties of Au NPs (5, 50, and 100?nm) and their implications on intestinal epithelial permeability in vitro. Au NPs aggregated in fasted gastric fluids and generated hydroxyl radicals in the presence of H2O2. Cell studies showed that GIT fluids incubation of Au NPs affected the cellular uptake of Au NPs but did not induce cytotoxicity or disturb the intestinal epithelial permeability. 相似文献
36.
37.
38.
39.
40.
M.-A. Fauroux A. Germa P. Tramini C. Nabet 《Revue d'épidémiologie et de santé publique》2019,67(4):223-231
BackgroundThe aim of this study was to estimate the prevalence of dental prosthetic treatment and to investigate the demographic, social, economic and medical factors associated with the use of fixed and removable dentures in a representative sample of adults living in France.MethodsThe data were obtained from the 2002–2003 Decennial Health Survey, a cross-sectional study of a representative sample of the population living in France, which included 29,679 adults. Information was collected by interview. The variables collected were fixed denture, removable denture, age, gender, number of children, area of residence, nationality, educational attainment, family social status, employment status, annual household income per capita, supplementary insurance, chronic disease, eyesight problems/glasses, hearing problems/hearing aids. Multinomial logistic regression models were used to study the relationship between prosthetic treatment and demographic, socioeconomic and medical characteristics unadjusted, adjusted for age and adjusted for all the characteristics.ResultsThe prevalence of prosthetic treatment was 34.6% (95% confidence interval (CI): [34.1; 35.2]) for fixed prosthetic dentures and 13.8% (95% CI: [13.4; 14.2]) for removable prosthetic dentures. We showed a gradient between educational attainment and removable dentures; the odds ratio adjusted for all the variables (aOR) associated with no or primary education compared to post-secondary education was 2.56; 95% CI: [2.09; 3.13]. When annual household income per capita was low, subjects were less likely to report fixed dentures (aOR = 0.68; 95% CI: [0.62; 0.75]) than those with high annual household income per capita. Individuals without insurance less often reported fixed dentures than those with private insurance. Those reporting chronic disease were less likely to report fixed dentures (aOR = 0.87; 95% CI: [0.79; 0.95]) but more likely to report removable dentures (aOR = 1.29; 95% CI: [1.17; 1.43]) than those without chronic disease.ConclusionThis study reveals social, economic and medical inequalities in fixed and removable prosthetic treatment among adults in France. 相似文献